{"cik":1784440,"taxonomy":"us-gaap","tag":"OperatingLeaseRightOfUseAsset","label":"Operating Lease, Right-of-Use Asset","description":"Amount of lessee's right to use underlying asset under operating lease.","entityName":"BIOSCIENCE HEALTH INNOVATIONS INC.","units":{"USD":[{"end":"2024-12-31","val":0,"accn":"0001185185-26-001133","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-30","frame":"CY2024Q4I"},{"end":"2025-12-31","val":61236,"accn":"0001185185-26-001133","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-30"},{"end":"2025-12-31","val":61236,"accn":"0001185185-26-001775","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-11"},{"end":"2025-12-31","val":61236,"accn":"0001096906-26-001173","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-07","frame":"CY2025Q4I"},{"end":"2026-03-31","val":48114,"accn":"0001185185-26-001775","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-11","frame":"CY2026Q1I"},{"end":"2026-06-30","val":34992,"accn":"0001096906-26-001173","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-07","frame":"CY2026Q2I"}]}}